Gillian Hawcroft

1.4k total citations
17 papers, 1.2k citations indexed

About

Gillian Hawcroft is a scholar working on Pharmacology, Molecular Biology and Genetics. According to data from OpenAlex, Gillian Hawcroft has authored 17 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmacology, 7 papers in Molecular Biology and 5 papers in Genetics. Recurrent topics in Gillian Hawcroft's work include Inflammatory mediators and NSAID effects (12 papers), Estrogen and related hormone effects (5 papers) and Cancer, Lipids, and Metabolism (4 papers). Gillian Hawcroft is often cited by papers focused on Inflammatory mediators and NSAID effects (12 papers), Estrogen and related hormone effects (5 papers) and Cancer, Lipids, and Metabolism (4 papers). Gillian Hawcroft collaborates with scholars based in United Kingdom, Italy and Germany. Gillian Hawcroft's co-authors include Mark A. Hull, Melvyn Smith, Sarah H. Gardner, P. Louise Coletta, Alexander F. Markham, Keith Chapple, Andrea Belluzzi, Constanze Bonifer, Paul M. Loadman and Elizabeth J. Cartwright and has published in prestigious journals such as The Journal of Cell Biology, Blood and Gastroenterology.

In The Last Decade

Gillian Hawcroft

17 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gillian Hawcroft United Kingdom 15 568 447 277 276 255 17 1.2k
Jason R. Mann United States 13 706 1.2× 491 1.1× 350 1.3× 309 1.1× 332 1.3× 14 1.4k
Weigang Tong United States 18 451 0.8× 632 1.4× 270 1.0× 194 0.7× 198 0.8× 30 1.4k
Gerhard Sperl United States 9 770 1.4× 567 1.3× 268 1.0× 432 1.6× 231 0.9× 15 1.4k
Russell D. Klein United States 20 305 0.5× 524 1.2× 229 0.8× 290 1.1× 246 1.0× 24 1.1k
Angela M. Acquaviva Italy 19 294 0.5× 427 1.0× 220 0.8× 177 0.6× 145 0.6× 33 1.1k
Susan C. Kirkland United Kingdom 17 858 1.5× 567 1.3× 535 1.9× 550 2.0× 313 1.2× 29 1.8k
N S Paranka United States 8 766 1.3× 334 0.7× 253 0.9× 425 1.5× 211 0.8× 10 1.1k
Ching-Shih Chen United States 11 432 0.8× 468 1.0× 180 0.6× 237 0.9× 134 0.5× 12 1.1k
Li Zhu China 19 316 0.6× 605 1.4× 413 1.5× 144 0.5× 162 0.6× 51 1.5k
Bernard D. Gary United States 20 368 0.6× 749 1.7× 200 0.7× 117 0.4× 102 0.4× 40 1.3k

Countries citing papers authored by Gillian Hawcroft

Since Specialization
Citations

This map shows the geographic impact of Gillian Hawcroft's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gillian Hawcroft with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gillian Hawcroft more than expected).

Fields of papers citing papers by Gillian Hawcroft

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gillian Hawcroft. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gillian Hawcroft. The network helps show where Gillian Hawcroft may publish in the future.

Co-authorship network of co-authors of Gillian Hawcroft

This figure shows the co-authorship network connecting the top 25 collaborators of Gillian Hawcroft. A scholar is included among the top collaborators of Gillian Hawcroft based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gillian Hawcroft. Gillian Hawcroft is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Hull, Mark A., Richard Cuthbert, Daniel Scott, et al.. (2017). Paracrine cyclooxygenase-2 activity by macrophages drives colorectal adenoma progression in the Apc Min/+ mouse model of intestinal tumorigenesis. Scientific Reports. 7(1). 6074–6074. 16 indexed citations
2.
Young, Alastair L., Gillian Hawcroft, Sarah Perry, et al.. (2013). Regional differences in prostaglandin E2 metabolism in human colorectal cancer liver metastases. BMC Cancer. 13(1). 92–92. 7 indexed citations
3.
Hawcroft, Gillian, Milène Volpato, Gemma Marston, et al.. (2012). The omega‐3 polyunsaturated fatty acid eicosapentaenoic acid inhibits mouse MC‐26 colorectal cancer cell liver metastasis via inhibition of PGE2‐dependent cell motility. British Journal of Pharmacology. 166(5). 1724–1737. 48 indexed citations
4.
Hawcroft, Gillian, Paul M. Loadman, Andrea Belluzzi, & Mark A. Hull. (2010). Effect of Eicosapentaenoic Acid on E-type Prostaglandin Synthesis and EP4 Receptor Signaling Human Colorectal Cancer Cells. Neoplasia. 12(8). 618–IN2. 70 indexed citations
5.
Hawcroft, Gillian, et al.. (2006). Prostaglandin E2-EP4 receptor signalling promotes tumorigenic behaviour of HT-29 human colorectal cancer cells. Oncogene. 26(21). 3006–3019. 67 indexed citations
6.
Wilson, Jonathan M., P. Louise Coletta, Richard Cuthbert, et al.. (2005). Macrophage Migration Inhibitory Factor Promotes Intestinal Tumorigenesis. Gastroenterology. 129(5). 1485–1503. 124 indexed citations
7.
Gardner, Sarah H., Gillian Hawcroft, & Mark A. Hull. (2004). Effect of nonsteroidal anti-inflammatory drugs on β-catenin protein levels and catenin-related transcription in human colorectal cancer cells. British Journal of Cancer. 91(1). 153–163. 46 indexed citations
8.
Hawcroft, Gillian, Sarah H. Gardner, & Mark A. Hull. (2004). Expression of prostaglandin D2 receptors DP1 and DP2 by human colorectal cancer cells. Cancer Letters. 210(1). 81–84. 14 indexed citations
9.
Hull, Mark A., et al.. (2004). Prostaglandin EP receptors: Targets for treatment and prevention of colorectal cancer?. Molecular Cancer Therapeutics. 3(8). 1031–1039. 130 indexed citations
10.
Hawcroft, Gillian, Sarah H. Gardner, & Mark A. Hull. (2003). Activation of Peroxisome Proliferator-Activated Receptor γ Does Not Explain the Antiproliferative Activity of the Nonsteroidal Anti-Inflammatory Drug Indomethacin on Human Colorectal Cancer Cells. Journal of Pharmacology and Experimental Therapeutics. 305(2). 632–637. 22 indexed citations
11.
Hull, Mark A., Sarah H. Gardner, & Gillian Hawcroft. (2003). Activity of the non-steroidal anti-inflammatory drug indomethacin against colorectal cancer. Cancer Treatment Reviews. 29(4). 309–320. 73 indexed citations
12.
Coletta, P. Louise, Albrecht Müller, Elena Jones, et al.. (2003). Lymphodepletion in the ApcMin/+ mouse model of intestinal tumorigenesis. Blood. 103(3). 1050–1058. 48 indexed citations
13.
14.
Chapple, Keith, et al.. (2002). Paracrine cyclooxygenase-2-mediated signalling by macrophages promotes tumorigenic progression of intestinal epithelial cells. Oncogene. 21(47). 7175–7186. 35 indexed citations
15.
Chapple, Keith, Elizabeth J. Cartwright, Gillian Hawcroft, et al.. (2000). Localization of Cyclooxygenase-2 in Human Sporadic Colorectal Adenomas. American Journal Of Pathology. 156(2). 545–553. 187 indexed citations
16.
Smith, Melvyn, Gillian Hawcroft, & Mark A. Hull. (2000). The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells. European Journal of Cancer. 36(5). 664–674. 230 indexed citations
17.
Alphey, Luke, et al.. (1997). KLP38B: A Mitotic Kinesin-related Protein That Binds PP1. The Journal of Cell Biology. 138(2). 395–409. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jason R. Mann Breakdown of academic impact, for papers by Weigang Tong Breakdown of academic impact, for papers by Gerhard Sperl Breakdown of academic impact, for papers by Russell D. Klein Breakdown of academic impact, for papers by Angela M. Acquaviva Breakdown of academic impact, for papers by Susan C. Kirkland Breakdown of academic impact, for papers by N S Paranka Breakdown of academic impact, for papers by Ching-Shih Chen Breakdown of academic impact, for papers by Li Zhu Breakdown of academic impact, for papers by Bernard D. Gary
Rankless by CCL
2026